BioMerieux EBIT 2017-2023 | BMXMF
- BioMerieux EBIT for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- BioMerieux EBIT for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- BioMerieux 2023 annual EBIT was $0.475B, a 23.18% decline from 2022.
- BioMerieux 2022 annual EBIT was $0.619B, a 33.31% decline from 2021.
- BioMerieux 2021 annual EBIT was $0.928B, a 46.91% increase from 2020.
BioMerieux Annual EBIT (Millions of US $) |
|
---|---|
2023 | $475 |
2022 | $619 |
2021 | $928 |
2020 | $631 |
2019 | $415 |
2018 | $406 |
2017 | $356 |
2016 | $313 |
2015 | $ |
BioMerieux Quarterly EBIT (Millions of US $) |
|
---|---|
2023-12-31 | |
2023-06-30 | |
2022-12-31 | |
2022-06-30 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 | |
2017-06-30 | |
2016-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $13.087B | $3.977B |
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $98.658B | 12.24 |
Cencora (COR) | United States | $49.082B | 18.10 |
DiDi Global (DIDIY) | China | $23.427B | 0.00 |
ICON (ICLR) | Ireland | $17.504B | 15.59 |
Natera (NTRA) | United States | $16.570B | 0.00 |
Viatris (VTRS) | United States | $15.624B | 4.81 |
Avantor (AVTR) | United States | $15.178B | 22.75 |
Revvity (RVTY) | United States | $14.682B | 25.50 |
CochLear (CHEOY) | Australia | $12.998B | 0.00 |
Solventum (SOLV) | United States | $12.357B | 0.00 |
Doximity (DOCS) | United States | $11.372B | 67.31 |
Medpace Holdings (MEDP) | United States | $11.301B | 31.84 |
Charles River Laboratories (CRL) | United States | $11.285B | 21.81 |
HealthEquity (HQY) | United States | $8.756B | 47.52 |
Sonic Healthcare (SKHHY) | Australia | $8.590B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $7.202B | 33.53 |
Life Times (LTH) | United States | $5.139B | 34.01 |
Sotera Health (SHC) | United States | $4.509B | 24.12 |
Organon (OGN) | United States | $4.144B | 4.18 |
Surgery Partners (SGRY) | United States | $3.996B | 44.27 |
BrightSpring Health Services (BTSG) | United States | $3.489B | 74.22 |
PACS (PACS) | United States | $3.347B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.580B | 0.00 |
Concentras Parent (CON) | United States | $2.505B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.471B | 0.00 |
Premier (PINC) | United States | $2.314B | 11.55 |
Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.016B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
Teladoc Health (TDOC) | United States | $1.689B | 0.00 |
Progyny (PGNY) | United States | $1.540B | 27.08 |
Pediatrix Medical (MD) | United States | $1.371B | 13.41 |
Establishment Labs Holdings (ESTA) | $1.266B | 0.00 | |
CareDx (CDNA) | United States | $1.252B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.058B | 7.16 |
Embecta (EMBC) | United States | $0.910B | 6.07 |
Agilon Health (AGL) | United States | $0.890B | 0.00 |
InnovAge Holding (INNV) | United States | $0.809B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
SBC Medicals (SBC) | United States | $0.723B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
DocGo (DCGO) | United States | $0.411B | 15.46 |
Enhabit (EHAB) | United States | $0.403B | 34.83 |
COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
LifeMD (LFMD) | United States | $0.308B | 0.00 |
Sera Prognostics (SERA) | United States | $0.248B | 0.00 |
ModivCare (MODV) | United States | $0.231B | 12.54 |
Beauty Health (SKIN) | United States | $0.218B | 0.00 |
Biodesix (BDSX) | United States | $0.205B | 0.00 |
Nutex Health (NUTX) | United States | $0.152B | 0.00 |
MultiPlan (MPLN) | United States | $0.137B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
So-Young (SY) | China | $0.088B | 21.28 |
Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.049B | 0.00 |
NeueHealth (NEUE) | United States | $0.042B | 1.10 |
Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
Oncology Institute (TOI) | United States | $0.020B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
XWELL (XWEL) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
KindlyMD (KDLY) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |